Noguera-Castells, Aleix (Date of defense: 2022-01-31)
Modern oncology conceives solid tumours as organs by themselves, meaning that not only should the behaviour of cancer cells to be considered and evaluated therapeutically, but also the so-called tumour ...
Casal Domínguez, María (Date of defense: 2018-02-16)
Inflammatory myopathy (IM) is a heterogeneous group of diseases characterized by muscle weakness and inflammatory infiltrates on the muscle biopsy. But muscle involvement is not always present and other ...
Gómez Puerta, José Alfredo (Date of defense: 2007-10-03)
The antiphospholipid syndrome (APS) is an acquired prothrombotic syndrome characterized by venous or arterial thromboses and pregnancy morbidity. It can present as primary APS without any discernable ...
Gomes Monteiro Lopes Baptista, Maria João (Date of defense: 2012-10-10)
Glucocorticoids are frequently included in the chemotherapy regimens administered to patients with CLL because they are potent immunosuppressant agents and because they are able to induce apoptosis in ...
Calvo Sánchez, Marta (Date of defense: 2015-01-23)
Introduction: So far, HIV patients-tailored clinical guidelines, are based on the available recommendations for the general population plus on considering earlier initiation of antiretroviral therapy. ...
Nadal Sanmartin, Cristina (Date of defense: 2007-07-24)
1 INTRODUCCIÓN<br/><br/>El cáncer colorrectal (CCR) es la tercera causa de diagnóstico de cáncer en todo el mundo. El 11-27% de pacientes se diagnostican en estadio avanzado o metastático. De los ...
Costas Caudet, Laura (Date of defense: 2017-01-16)
Lymphoid neoplasms are a heterogeneous group of cancers characterized by the neoplastic or clonal proliferation of lymphoid cells in different stages of differentiation. The incidence rate of these ...
Burgos Rincón, Felip (Date of defense: 2013-09-12)
INTRODUCTION The deployment of new health care models based on the coordination between different levels is a priority at European level to manage the dysfunctions generated by health and social ...
Fernández Noguera, Patricia (Date of defense: 2016-02-04)
HER2 positivity defines a molecular subtype of breast cancer with an aggressive biological behaviour and poor prognosis. Its pharmacological targeting with the monoclonal antibody Trastuzumab, and later ...